Browse Category

Biotechnology 7 January 2026 - 12 January 2026

CG Oncology stock (CGON) jumps 29% on faster Phase 3 timeline — what to watch next week

CG Oncology shares jumped 29.3% to close at $54.20 on Friday, hitting a session high of $57.40 amid increased interest ahead of a critical bladder-cancer readout. Trading volume came in around 7.0 million shares.

12 January 2026

Biotechnology·NASDAQ:CGON·Stock Market

CRISPR Therapeutics stock (CRSP) drops into JPM week — what to watch next

CRISPR Therapeutics AG slipped 4.5% to $53.84 on Friday, putting the gene-editing stock under pressure as biotech leaders and investors gear up to converge in San Francisco this week.

12 January 2026

Biotechnology·NASDAQ:CRSP·Stock Market

Regencell Bioscience (RGC) stock swings 45% then closes up 10.6% — what to watch Monday

Regencell Bioscience Holdings Ltd shares closed Friday up 10.6% at $45.79, recovering sharply after dipping roughly 15% during the session. The Nasdaq-listed stock kicked off the day at $36.08 and swung between a low of $35.13 and a high of $50.92.

11 January 2026

Biotechnology·NASDAQ:RGC·Stock Market

Wave Life Sciences stock drops 7% into JPM Healthcare Conference week — what to know next

Shares of Wave Life Sciences Ltd dropped 6.7% on Friday, ending the day at $13.84. The stock swung between a high of $15.09 and a low of $13.76 during the session.

11 January 2026

Biotechnology·NASDAQ:WVE·Stock Market

CG Oncology stock jumps 29% on faster Phase 3 PIVOT-006 data clock — what to watch next

CG Oncology Inc shares surged nearly 29% on Friday, closing at $54.20 after hitting a session high of $57.36. The stock gained $12.25 during the day on volume of about 7.0 million shares.

11 January 2026

Biotechnology·NASDAQ:CGON·Stock Market

Lilly’s TuneLab AI drug platform lands in Schrödinger LiveDesign as biotech access broadens

Schrödinger announced it will integrate Eli Lilly’s TuneLab, an AI-driven drug discovery platform, into its LiveDesign software. This move offers biotech teams direct access to Lilly’s predictive models. “LiveDesign will be a priority platform partner for TuneLab workflows,” said Pat Lorton, Schrödinger’s software chief.

10 January 2026

Artificial Intelligence·Biotechnology·NASDAQ:RVTY·NASDAQ:SDGR·NYSE:LLY

CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

CRISPR Therapeutics AG shares slid on Friday, bucking a firmer broader market, after a regulatory filing flagged a chief financial officer’s share sale under a pre-arranged trading plan.

9 January 2026

Biotechnology·NASDAQ:BEAM·NASDAQ:CRSP·NASDAQ:EDIT·NASDAQ:NTLA·NASDAQ:VRTX·Pharmaceuticals·Stock Market

Why Regencell Bioscience (RGC) stock is moving today: choppy rebound after Nasdaq pauses

Regencell Bioscience Holdings Limited shares rose about 8.5% to $44.96 in midday trading on Friday, clawing back from an early dip. The stock has swung between $35.13 and $50.92 in the session, with more than 1.1 million shares traded.

9 January 2026

Biotechnology·NASDAQ:RGC·Stock Market

CG Oncology stock jumps 25% after pulling Phase 3 PIVOT-006 bladder cancer data into 1H 2026

CG Oncology shares jumped on Friday after the company moved up the expected timing for late-stage trial results in bladder cancer. The stock was up 25.1% at $52.45 by 11:52 EST, versus Thursday’s close of $41.93, after trading between $41.63 and $52.64 on the day as volume topped 4.1 million shares.

9 January 2026

Biotechnology·NASDAQ:CGOI·Pharmaceutical News·Stock Market

Eli Lilly stock (LLY) slips as Ventyx deal, Zepbound arthritis data and TuneLab AI tie-up come into view

Eli Lilly and Company shares were down about 0.4% at $1,081 in morning trade on Friday. The drugmaker said this week it will buy autoimmune developer Ventyx Biosciences for $1.2 billion in cash, bringing oral candidates for inflammatory bowel disease into its pipeline. The $14-a-share offer is slated to close in the first half of 2026, and Cantor Fitzgerald analyst Carter Gould described the price as “borderline immaterial” for Lilly.

9 January 2026

Biotechnology·NYSE:LLY·Pharmaceuticals·Stock Market

MoonLake stock jumps after FDA feedback clears path for sonelokimab filing without new HS trials

MoonLake Immunotherapeutics shares jumped 27% to $14.34 on Thursday after the biotech said U.S. regulators supported a route to file its hidradenitis suppurativa treatment without doing more trials for the skin disease. The stock churned between $11.20 and $17.28, and roughly 24 million shares traded.

8 January 2026

Biotechnology·NASDAQ:MLTX·Pharmaceuticals·Stock Market

Merck stock climbs on Wolfe upgrade as Cidara deal closes and Gardasil questions linger

Merck & Co shares rose 1.5% to $110.20 in afternoon trading on Thursday after Wolfe Research upgraded the drugmaker, outpacing a softer health-care sector. The stock traded as high as $112.08 and as low as $107.94, while AbbVie slid about 3.9% and the S&P 500 ETF was little changed.

8 January 2026

Biotechnology·NASDAQ:CDTX·NYSE:MRK·Pharmaceuticals·Stock Market

Immuneering (IMRX) stock jumps in premarket after 12-month pancreatic cancer survival update

Shares of Immuneering Corp jumped about 24% to $8.33 in premarket trading on Thursday, after the biotech released updated survival data for its lead pancreatic cancer program. The stock last closed at $6.74.

8 January 2026

Biotechnology·NASDAQ:IMRX·Pharmaceutical News·Stock Market

Amgen stock jumps on UBS buy call as Dark Blue deal sharpens focus on pipeline

Amgen shares rose 3.5% to $341.64 in Wednesday’s regular session and were last near that level after the bell. UBS assumed coverage with a buy rating and a $380 price target, saying it sees “upside from EPS and pipeline.”

8 January 2026

Biotechnology·NASDAQ:AMGN·NYSE:AMRX·Stock Market

Thermo Fisher stock slips after-hours as TD Cowen lifts target ahead of JPM talk, earnings

Thermo Fisher Scientific shares slipped about 0.6% in after-hours trading on Wednesday to $617.15, after swinging between $611.93 and $626.40 during the session.

8 January 2026

Biotechnology·Earnings Reports·NYSE:TMO·Stock Market

Viasat stock slides as Evergreen signs on for Inmarsat NexusWave, CFO sale hits tape

Viasat shares fell $4.89, or about 11.3%, to $38.57 on Wednesday, a day after the stock closed at $43.46. The shares traded between $38.27 and $43.58.

7 January 2026

Biotechnology·LSE:ISAT·NASDAQ:VSAT·Pharmaceuticals·Stock Market

Why Wave Life Sciences (WVE) stock is up today after Arrowhead’s obesity data spotlights INHBE

Wave Life Sciences shares rose 4.4% to $15.82 in midday trade on Wednesday. The stock has stayed in motion as investors circle back to obesity plays tied to a gene target called INHBE.

7 January 2026

Biotechnology·NASDAQ:ARWR·NASDAQ:WVE·Stock Market

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

Shares of Adaptive Biotechnologies rose 6.5% to $17.15 on Wednesday, after trading between $16.24 and $17.33, giving the company a market value of about $2.0 billion. The stock has traded between $4.32 and $21.89 over the past 52 weeks.

7 January 2026

Biotechnology·NASDAQ:ADPT·Stock Market

Structure Therapeutics stock climbs on $100 million Roche-Genentech patent deal; what investors watch next

Shares of Structure Therapeutics Inc rose 5.6% to $66.75 in late-morning trade on Wednesday, recovering from early swings as investors sized up a newly disclosed patent license deal tied to Roche and Genentech’s oral obesity drug effort.

7 January 2026

Biotechnology·NASDAQ:GPX

Pfizer stock gains early as UBS starts coverage; Bayer mRNA lawsuit adds fresh risk

Pfizer shares rose about 0.9% to $25.67 in morning trade on Wednesday, even as investors weighed a new patent lawsuit tied to its COVID-19 vaccine and a cautious call from UBS.

7 January 2026

Biotechnology·NASDAQ:BNTX·NASDAQ:MRNA·NYSE:PFE·XETRA:BAYN

Previous 1 … 7 8 9 10 11 … 21 Next

Biotechnology 7 January 2026 - 12 January 2026

CG Oncology stock (CGON) jumps 29% on faster Phase 3 timeline — what to watch next week

CRISPR Therapeutics stock (CRSP) drops into JPM week — what to watch next

Regencell Bioscience (RGC) stock swings 45% then closes up 10.6% — what to watch Monday

Wave Life Sciences stock drops 7% into JPM Healthcare Conference week — what to know next

CG Oncology stock jumps 29% on faster Phase 3 PIVOT-006 data clock — what to watch next

Lilly’s TuneLab AI drug platform lands in Schrödinger LiveDesign as biotech access broadens

CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

Why Regencell Bioscience (RGC) stock is moving today: choppy rebound after Nasdaq pauses

CG Oncology stock jumps 25% after pulling Phase 3 PIVOT-006 bladder cancer data into 1H 2026

Eli Lilly stock (LLY) slips as Ventyx deal, Zepbound arthritis data and TuneLab AI tie-up come into view

MoonLake stock jumps after FDA feedback clears path for sonelokimab filing without new HS trials

Merck stock climbs on Wolfe upgrade as Cidara deal closes and Gardasil questions linger

Immuneering (IMRX) stock jumps in premarket after 12-month pancreatic cancer survival update

Amgen stock jumps on UBS buy call as Dark Blue deal sharpens focus on pipeline

Thermo Fisher stock slips after-hours as TD Cowen lifts target ahead of JPM talk, earnings

Viasat stock slides as Evergreen signs on for Inmarsat NexusWave, CFO sale hits tape

Why Wave Life Sciences (WVE) stock is up today after Arrowhead’s obesity data spotlights INHBE

Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale

Structure Therapeutics stock climbs on $100 million Roche-Genentech patent deal; what investors watch next

Pfizer stock gains early as UBS starts coverage; Bayer mRNA lawsuit adds fresh risk

TechStock² Updates

SK hynix loses 53 trillion won in market value, a sum close to its new fab investment

Cipher Digital (NASDAQ:CIFR) Shares Drop Amid Restricted Cash Issues Affecting Data-Center Appraisal

DoubleVerify (NYSE:DV) Rises 13% Following Nielsen Bid as Merger Gap Closes

Vistra (NYSE:VST) Shares Fall Despite 31% Rise in EBITDA, Maintains 2026 Outlook

Wendy’s (NASDAQ:WEN) to Slash Dividend, Releasing Approximately $53 Million as U.S. Sales Fall Behind Other Burger Chains

Top Stock Picks

Constellation Energy

AerCap

Walt Disney

AIG

Cheniere Energy

Live updates

Investment Disclaimer